As reported Tuesday by The Florida Capital Star, the U.S. Food and Drug Administration (FDA) revoked the Emergency Use Authorization (EUA) for monoclonal antibodies as a treatment for COVID-19, but did not provide the data is cited in making its decision.
Without the help of the FDA, which did not return a follow up comment request Wednesday, The Star was able to locate what appears to be the data used in the decision-making process. It is on the website for the National Institute of Health (NIH), which is headed by Dr. Anthony Fauci.
Read More